Earnings
RCKT
34.20
+1.57%
0.53
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
297.10M
185.62M
--
--
--
--
0.00
--
--
--
4.63M
--
487.35M
70.64M
--
--
--
30.82M
--
--
2.02M
103.48M
590.82M
--
--
0.00
--
--
--
--
--
25.26M
--
--
--
835.00K
32.62M
54.05M
--
--
--
634.00K
54.69M
87.31M
610.00K
825.79M
-322.84M
0.00
--
--
503.52M
503.52M
590.82M
FY 2019-12-31
185.38M
118.73M
--
--
--
--
0.00
--
--
--
3.64M
--
307.75M
31.57M
--
0.00
--
30.82M
--
--
1.98M
64.37M
372.12M
--
--
0.00
--
--
--
--
--
17.97M
--
--
--
340.00K
18.31M
45.05M
--
--
--
1.47M
46.52M
64.82M
548.00K
489.93M
-183.14M
-53.00K
--
--
307.30M
307.30M
372.12M
FY 2018-12-31
111.36M
94.38M
--
--
--
--
0.00
--
--
--
3.36M
--
209.09M
2.03M
--
7.40M
--
30.82M
--
--
1.98M
42.23M
251.31M
--
--
0.00
--
--
--
--
--
14.78M
--
--
--
589.00K
15.37M
41.45M
--
--
--
457.00K
41.90M
57.28M
452.00K
300.25M
-105.87M
-668.00K
--
--
194.04M
194.04M
251.31M
FY 2017-12-31
18.14M
0.00
--
--
--
--
0.00
--
--
--
813.00K
--
18.95M
985.00K
--
--
--
0.00
--
--
207.00K
1.19M
20.15M
--
0.00
0.00
--
--
--
--
--
4.50M
--
--
--
25.00K
4.52M
0.00
--
--
--
107.00K
107.00K
4.63M
1000.00
5.41M
-31.36M
--
--
--
15.52M
15.52M
20.15M
FY 2016-12-31
29.80M
96.67M
--
--
--
--
0.00
--
--
--
1.88M
--
128.35M
1.13M
--
--
--
--
--
--
168.00K
1.30M
129.65M
--
1.59M
0.00
--
--
--
--
--
5.31M
--
--
--
138.00K
7.04M
48.96M
--
--
--
477.00K
49.44M
56.48M
270.00K
311.83M
-238.88M
--
--
--
73.17M
73.17M
129.65M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out RCKT latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze ROCKET PHARMACEU recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.